Fig. 4
From: The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice
Effect of Empagliflozin on neurogenesis after stroke. Number of Ki67+ cells in subventricular zone (SVZ) (a) and number of DCX+ cells in striatum (b) of non-diabetic controls (non-T2D), diabetic mice (T2D-VH) and diabetic mice treated with Empagliflozin (T2D-E) after stroke. Data are presented as mean ± SD. Statistical significance was calculated using two-way ANOVA followed by Benjamini, Krieger and Yekutieli multiple comparisons test. Results were considered statistically significant if p < 0.05. #denotes a difference between the contralateral and ipsilateral hemisphere within the same group. ##denotes p < 0.01, ###denotes p < 0.001. non-T2D n = 6, T2D-VH n = 7, T2D-E n = 8